Gilean McVean
Wellcome Trust Centre for Human Genetics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gilean McVean.
Scopus | 2011
David Evans; Alexander Dilthey; M. Pirinen; Tetyana Zayats; C. C. A. Spencer; Z. Su; Céline Bellenguez; Colin Freeman; Amy Strange; Gilean McVean; Peter Donnelly; J. J. Pointon; David Harvey; L. H. Appleton; T. Wordsworth; Tugce Karaderi; C Farrar; Paul Bowness; B. P. Wordsworth; Grazyna Kochan; U. Opperman; M Stone; L. Moutsianis; Stephen Leslie; Tony J. Kenna; Gethin P. Thomas; Linda A. Bradbury; Patrick Danoy; Matthew A. Brown; M. Ward
Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. Here we report the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 × 10−8 in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all our datasets (P < 5 × 10−6 overall, with support in each of the three datasets studied). We also show that polymorphisms of ERAP1, which encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation, only affect ankylosing spondylitis risk in HLA-B27–positive individuals. These findings provide strong evidence that HLA-B27 operates in ankylosing spondylitis through a mechanism involving aberrant processing of antigenic peptides.
PLOS Genetics | 2012
Stefano Lise; Yvonne L. Clarkson; Emma M. Perkins; Alexandra Kwasniewska; Elham Sadighi Akha; Ricardo Parolin Schnekenberg; Daumante Suminaite; Jilly Hope; Ian Baker; Lorna Gregory; Angie Green; Chris Allan; Sarah Lamble; Sandeep Jayawant; Gerardine Quaghebeur; M. Zameel Cader; Sarah Hughes; Richard J. E. Armstrong; Alexander Kanapin; Andrew J. Rimmer; Gerton Lunter; Iain Mathieson; Jean-Baptiste Cazier; David Buck; Jenny C. Taylor; David R. Bentley; Gilean McVean; Peter Donnelly; Samantha J. L. Knight; Mandy Jackson
β-III spectrin is present in the brain and is known to be important in the function of the cerebellum. Heterozygous mutations in SPTBN2, the gene encoding β-III spectrin, cause Spinocerebellar Ataxia Type 5 (SCA5), an adult-onset, slowly progressive, autosomal-dominant pure cerebellar ataxia. SCA5 is sometimes known as “Lincoln ataxia,” because the largest known family is descended from relatives of the United States President Abraham Lincoln. Using targeted capture and next-generation sequencing, we identified a homozygous stop codon in SPTBN2 in a consanguineous family in which childhood developmental ataxia co-segregates with cognitive impairment. The cognitive impairment could result from mutations in a second gene, but further analysis using whole-genome sequencing combined with SNP array analysis did not reveal any evidence of other mutations. We also examined a mouse knockout of β-III spectrin in which ataxia and progressive degeneration of cerebellar Purkinje cells has been previously reported and found morphological abnormalities in neurons from prefrontal cortex and deficits in object recognition tasks, consistent with the human cognitive phenotype. These data provide the first evidence that β-III spectrin plays an important role in cortical brain development and cognition, in addition to its function in the cerebellum; and we conclude that cognitive impairment is an integral part of this novel recessive ataxic syndrome, Spectrin-associated Autosomal Recessive Cerebellar Ataxia type 1 (SPARCA1). In addition, the identification of SPARCA1 and normal heterozygous carriers of the stop codon in SPTBN2 provides insights into the mechanism of molecular dominance in SCA5 and demonstrates that the cell-specific repertoire of spectrin subunits underlies a novel group of disorders, the neuronal spectrinopathies, which includes SCA5, SPARCA1, and a form of West syndrome.
Journal of The Royal Statistical Society Series B-statistical Methodology | 2002
David J. Balding; Andrew D. Carothers; Jonathan Marchini; L R Cardon; Atam Vetta; Bob Griffiths; B. S. Weir; W. G. Hill; Darlene Goldstein; Korbinian Strimmer; Simon Myers; Mark A. Beaumont; C. A. Glasbey; C. D. Mayer; Sylvia Richardson; Clare Marshall; Richard Durrett; Rasmus Nielsen; Peter M. Visscher; S.A. Knott; C. S. Haley; Roderick D. Ball; Christine A. Hackett; Susan Holmes; Dirk Husmeier; Ritsert C. Jansen; Cajo J F Ter Braak; Chris A. Maliepaard; Martin P. Boer; Paul Joyce
David J. Balding .Imperial College School of Medicine, London/ I extendmy apologies to the authors that an unavoidable commitment arising unexpectedly in the 18 hours before the meeting robbed me of my final preparation, so that my comments at the meeting were poorly presented. I shall try to do a better job in this written version, and to leave enough space I shall omit my introductory comments about the role of statisticians in bioinformatics.
Bioinformatics | 2016
Luke Jostins; Gilean McVean
Motivation: For many classes of disease the same genetic risk variants underly many related phenotypes or disease subtypes. Multinomial logistic regression provides an attractive framework to analyze multi-category phenotypes, and explore the genetic relationships between these phenotype categories. We introduce Trinculo, a program that implements a wide range of multinomial analyses in a single fast package that is designed to be easy to use by users of standard genome-wide association study software. Availability and implementation: An open source C implementation, with code and binaries for Linux and Mac OSX, is available for download at http://sourceforge.net/projects/trinculo Supplementary information: Supplementary data are available at Bioinformatics online. Contact: [email protected]
Society for Endocrinology BES 2013 | 2013
Paul Newey; M. Andrew Nesbit; Andrew J. Rimmer; Rosie Head; Caroline M. Gorvin; Moustafa Attar; Lorna Gregory; John Wass; David Buck; Niki Karavitaki; Ashley Grossman; Gilean McVean; Olaf Ansorge; Rajesh Thakker
Institute of Health and Biomedical Innovation | 2012
Julian Maller; Gilean McVean; Jake K. Byrnes; Damjan Vukcevic; Kimmo Palin; Z. Su; Joanna M. M. Howson; Adam Auton; Simon Myers; Alex Morris; Matti Pirinen; Matthew A. Brown; Paul R. Burton; Mark J. Caulfield; A. Compston; Martin Farrall; A. S. Hall; Andrew T. Hattersley; Adrian V. S. Hill; Christopher G. Mathew; Marcus Pembrey; J Satsangi; Michael R. Stratton; Jane Worthington; N. Craddock; Willem H. Ouwehand; M Parkes; Nazneen Rahman; Audrey Duncanson; John A. Todd
Faculty of Health; Institute of Health and Biomedical Innovation | 2010
Amy Strange; Francesca Capon; C. C. A. Spencer; Joanne Knight; Michael E. Weale; Michael H. Allen; Anne Barton; Céline Bellenguez; Judith G.M. Bergboer; J. M. BlackweL; Elvira Bramon; Suzannah Bumpstead; Juan-Pablo Casas; Michael J. Cork; Aiden Corvin; Panagiotis Deloukas; Alexander Dilthey; Audrey Duncanson; Sarah Edkins; X. EstiviL; Oliver FitzGerald; C. FrEman; Emiliano Giardina; Elizabeth E. Gray; Angelika Hofer; Ulrike Hüffmeier; Sarah Hunt; Alan D. Irvine; Janusz Jankowski; Brian Kirby